Uniphore Acquiring ActionIQ and Infoworks to Deliver the Industry’s First Zero Data AI Cloud
Strategic acquisitions unleash Enterprise data to create knowledge, fine tune AI models, create powerful AI agents and drive business transformation.
Uniphore, the global leader in Enterprise AI, today announced it is acquiring two industry-leading data powerhouses, ActionIQ and Infoworks, which significantly expands its AI-powered offerings. These strategic acquisitions extend Uniphore’s comprehensive end-to-end Enterprise AI platform and will deliver the industry’s first Zero Data AI Cloud.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205133623/en/

Uniphore is acquiring two industry-leading data powerhouses, ActionIQ and Infoworks, which significantly expands its AI-powered offerings. These strategic acquisitions extend Uniphore’s comprehensive end-to-end Enterprise AI platform and will deliver the industry’s first Zero Data AI Cloud. (Graphic: Business Wire)
A Zero Data AI Cloud enables enterprises to overcome the largest barriers of AI adoption – data access, accuracy, flexibility and data sovereignty. It removes data bottlenecks and delivers powerful AI capabilities while preserving customers’ existing data landscape and avoids complex integration challenges. Uniphore’s Zero Data AI Cloud is built on an infrastructure-agnostic architecture that creates a seamless data fabric across any data platform, enterprise application, or cloud environment.
By bringing Uniphore, ActionIQ and Infoworks together, enterprise customers will have access to an entire suite of AI capabilities that empowers organizations to move beyond proof-of-concept AI trials into full scale implementation, accelerating their digital transformation.
In addition to their industry-leading customer data solutions, ActionIQ brings their Composable Zero-copy Data Platform, which enables enterprises to connect all data, from anywhere, and make it AI-ready without requiring any long integration or ETL projects. Infoworks brings their Enterprise Data Platform which includes intelligent AI data agents that can discover, identify, organize, catalogue and clean enterprise data with little human supervision.
Their combined expertise and innovative technology enable enterprises to leverage all their data for AI initiatives without the need to move, transform, or copy it, and will accelerate the time to achieve results down to weeks, not years, all while maintaining high standards of governance and security.
“This is a defining moment for Enterprise AI,” said Umesh Sachdev, CEO and co-founder of Uniphore. “With the acquisitions of ActionIQ and Infoworks, Uniphore is enabling a Zero Data AI Cloud for the world’s largest companies, equipping them with the tools to fast-track AI deployments and drive measurable business outcomes.”
Tasso Argyros, CEO and co-founder of ActionIQ said, "At ActionIQ we’ve been hyper-focused on data and helped create and now lead the massive category of Customer Data Platforms, helping dozens of F1000 enterprises transform their Customer Experience. It is my belief that the future of CDPs is AI and CX Agents. Bringing together Uniphore's industry-leading AI capabilities and ActionIQ's data and CX capabilities will allow us to continue leading the market and deliver world class solutions to the world.”
"Data has long been a challenge for enterprises to modernize their operations and embracing AI innovations," said Amar Arsikere, Founder at Infoworks. "At Infoworks, we are redefining data engineering with groundbreaking automation that seamlessly handles every data task for any kind of data. By joining forces with Uniphore, we now deliver a comprehensive Data + AI solution that accelerates the development of Enterprise AI applications and empowers organizations to unlock their full potential."
Powering Business Transformation with a Zero Data AI Cloud
Uniphore is pioneering a revolutionary approach leveraging a multi-layered AI architecture comprised of a composable data layer, knowledge layer, model layer and agentic layer. Within each layer, Uniphore has feature-rich solutions, with continued investments planned in each area.
- Composable Data Layer
Organizations can instantly harness their enterprise data without complex migrations or copies. Enterprises can maintain complete control of their data assets across global operations. It reduces AI deployment time from months to weeks.
- Knowledge Layer
Enterprise data is transformed into an AI-ready knowledge lake. It ensures that AI outputs are grounded in an organization’s business reality without hallucinations. This allows organizations to fully leverage and protect their institutional knowledge and experience.
- Model Layer
All the capabilities in this layer enable countless options for enterprises to easily pick relevant foundational models and/or work with multiple models to meet their business needs. Within the model layer there are also tooling capabilities to easily create fine-tuned industry and enterprise specific small language models.
- Agentic Layer
This is where digital transformation is accelerated with ready-to-deploy AI agents across core functions such as customer service, marketing, HR, sales, and more. Further, this layer empowers the functional user and citizen developer to build and manage intelligent and personalized AI agents for specific business needs and workflow automation.
With this unique 4-layer approach, customers now can fully leverage Uniphore’s suite of end-to-end AI capabilities through an open architecture, while ensuring data sovereignty and enterprise-grade scalability. Organizations maintain complete control while deploying AI solutions across any scale—from department level solutions all the way to sophisticated global operations.
Enterprise AI That Delivers Results
Large enterprises are increasingly looking for solutions that enable them to become more agile, responsive, and data-driven in their decision-making. With the acquisition of ActionIQ and Infoworks, Uniphore is the only Enterprise AI company with an end-to-end solution for a Zero Data AI Cloud that delivers:
- Accelerated Time to Value
Now, customers can deploy enterprise-wide AI solutions in weeks, by enabling seamless data access. With support for multi-cloud and virtual private cloud deployments, enterprises’ needs for flexible and secure access to data are achieved. Further, Uniphore delivers enterprises an end-to-end AI stack with pre-built applications today for customer service, sales, HR, marketing, and more as well as the capabilities to build their own intelligent agents.
- Superior AI Performance
High accuracy is now attainable because of fine-tuned industry and enterprise models that access an enterprise’s knowledge in any data format. The Uniphore solution also delivers consistent results aligned with any company’s business context beyond what traditional RAG solutions provide. Because of Uniphore’s open architecture and orchestration capabilities, enterprises can leverage their existing best-in-class solutions, based on business needs, to support multiple models.
- Enterprise Data Freedom
The Uniphore Zero Data AI Cloud enables the use of multi-modal data across any platform, architecture, or application. There no longer needs to be any disruption to existing systems and workflows and no vendor lock-in. This gives customers complete control over sensitive enterprise knowledge and information.
This strategic move from Uniphore cements its leadership position as an Enterprise AI innovator. Uniphore will continue to deliver industry-leading solutions, including expanding the ActionIQ composable CDP solution to capitalize on the multi-billion-dollar CDP market opportunity and will continue to enhance its established portfolio of solutions that currently are in use at some of the world’s largest corporations. The ActionIQ solution is currently listed as a leader in the Forrester Wave competitive report on Customer Data Platforms.
For additional information on these acquisitions, please see our information page, which has a fact sheet on ActionIQ and afact sheet on Infoworks. Tidal Partners LLC acted as exclusive financial advisor to Uniphore on the transaction.
About Uniphore
Uniphore is a leading B2B AI-native company with decades of proven success. Engineered for scalability and tailored for enterprise needs, we drive AI transformation that delivers real business impact across multiple industries and the largest global deployments. Our Zero Data AI Cloud is built on a multimodal AI and data platform and is at the heart of this transformation, enabling businesses to swiftly deploy AI across the enterprise. With our Zero-Data AI Cloud, organizations can harness their data and create scalable, domain-specific AI models to democratize enterprise knowledge—all while ensuring security, sovereignty, and rapid value delivery. Today, Uniphore’s technology empowers over 750,000 end-users across 1,600 enterprises in 20 countries. Discover the unmatched capabilities of Uniphore—because there’s no AI like it™.
For more information about Uniphore’s solutions, visit [www.uniphore.com]
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205133623/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study26.1.2026 09:00:00 CET | Press release
Aesyra SA, a Swiss medtech company developing innovative digital therapeutics for dental and sleep-related disorders, today announced the successful completion of its clinical investigation evaluating the efficacy and safety of AesyBite™ Active, an intelligent oral appliance designed to treat and prevent sleep bruxism through biofeedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126533019/en/ AesyBite Custom smart nightguard by Aesyra SA. The clinical investigation demonstrated that AesyBite™ Active achieved a statistically significant and clinically meaningful reduction in sleep bruxism activity, exceeding the predefined performance target. Strong and robust clinical outcomes In the study (Identifier: NCT06153810), involving 26 adult patients with confirmed sleep bruxism, activation of the AesyBite Active biofeedback system resulted in a 60.6% reduction in total sleep bruxism duration per hour compared to baseline
Franklin Templeton Aligns Alternative Credit Firms Under BSP Brand26.1.2026 08:58:00 CET | Press release
Benefit Street Partners and Alcentra align under a single, refreshed BSP brand.Move reflects client demand for a specialist, integrated and global credit platform.Franklin Templeton’s alternative credit platform on track to exceed $100bn in 2026.BSP outlines further growth plans including expansion in the Middle East and Asia.New research says 51% of institutional investors will increase credit allocation in 2026.81% of institutions say a specialist focus on credit is the top attribute for performance. Franklin Templeton’s US and European alternative credit businesses, Benefit Street Partners and Alcentra, have now aligned under an updated Benefit Street Partners (BSP) brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260123270080/en/ David Manlowe, CEO of Benefit Street Partners The move is the final step in BSP and Alcentra’s integration – two pioneering alternative credit firms that Franklin Templeton acquired in 2019
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results26.1.2026 08:00:00 CET | Press release
In its first financial results announcement after the spin-off, Samsung Bioepis recorded FY2025 revenue of KRW 1.672 trillion, highest annual revenue in its 14-year historyExcluding milestone revenue, annual sales revenue grew 28% year-over-year (YoY), recording KRW 1.626 trillion, with 101% YoY growth in operating profit to KRW 330.8 billion Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced financial results for the fourth quarter and fiscal year 2025. “We are very pleased to report strong year-to-date sales growth in our first financial results following the spin-off. Our organic growth has been driven by solid performance across our biosimilars portfolio," said Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings. “We are continuing to make meaningful progress in our regulatory and commercial milestones with our existing biosimilars portfolio, while strategically
Syngenta and Statkraft Sign Five-Year Virtual Power Purchase Agreement26.1.2026 08:00:00 CET | Press release
Virtual wind PPA with guarantees of origin to decarbonize Syngenta's plants in Europe Important element in carbon reduction journey for Syngenta AG Syngenta, one of the world’s biggest agricultural innovation companies, and Statkraft, a leading provider of innovative green energy solutions in Europe, have signed a virtual power purchase agreement (vPPA) covering Syngenta’s CP & Seeds operations for a period of five years. The volume amounts to 125 GWh per year and a total of 625 GWh of green electricity by the end of the contract in 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260125701845/en/ Syngenta and Statkraft sign five-year virtual power purchase agreement With the vPPA, Statkraft is supporting Syngenta in advancing its sustainability strategy through the purchase of renewable energy. "This is Syngenta's first vPPA, marking a pivotal step in our decarbonization strategy," said Rachel Stenson Bugnon, Global Hea
Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity26.1.2026 08:00:00 CET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that it has completed the regulatory submission for XEOMIN® (incobotulinumtoxinA) for the treatment of spasticity of the lower and upper limb in children and adolescents aged 2–17 years in the European Union (EU) and European Economic Area (EEA). If approved, the indication would expand access to an established botulinum neurotoxin therapy for some of the youngest and most vulnerable patients across Europe. Spasticity is a common and often debilitating condition in children and adolescents with certain neurological conditions, leading to increased muscle tone that can significantly limit movement, function and independence. One of the most common underlying causes of spasticity in children is cerebral palsy (CP), the most frequent motor disability in childhood, with spastic forms accounting for approximately 80% of all cases. In more severe cases, spasticity associated with CP can also affect spe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom